TR200402343T4 - Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit - Google Patents

Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit

Info

Publication number
TR200402343T4
TR200402343T4 TR2004/02343T TR200402343T TR200402343T4 TR 200402343 T4 TR200402343 T4 TR 200402343T4 TR 2004/02343 T TR2004/02343 T TR 2004/02343T TR 200402343 T TR200402343 T TR 200402343T TR 200402343 T4 TR200402343 T4 TR 200402343T4
Authority
TR
Turkey
Prior art keywords
heterocyclyl
benzene
antithrombotic
anticoagulant agent
pyridine sulfonamide
Prior art date
Application number
TR2004/02343T
Other languages
English (en)
Inventor
Michel Altenburger Jean
Cremer Gerard
Lassalle Gilbert
Matrougui Mostafa
Original Assignee
Sanof� - Avent�S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanof� - Avent�S filed Critical Sanof� - Avent�S
Publication of TR200402343T4 publication Critical patent/TR200402343T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Mevcut bulusun konusu N-(heterosiklil) benzen veya sulfonamid piridin, preparatlari ve tedavide uygulamalaridir. Buna göre mevcut bulus bir formül [I] bilesigidir. Formül (I)
TR2004/02343T 2000-03-23 2001-03-22 Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit TR200402343T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0003724A FR2806722B1 (fr) 2000-03-23 2000-03-23 Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
TR200402343T4 true TR200402343T4 (tr) 2004-12-21

Family

ID=8848428

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02343T TR200402343T4 (tr) 2000-03-23 2001-03-22 Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit

Country Status (35)

Country Link
US (1) US6680329B2 (tr)
EP (1) EP1268469B1 (tr)
JP (1) JP2003528098A (tr)
KR (1) KR100791693B1 (tr)
CN (1) CN1183128C (tr)
AR (1) AR029900A1 (tr)
AT (1) ATE269325T1 (tr)
AU (2) AU4661701A (tr)
BG (1) BG65863B1 (tr)
BR (1) BR0109385A (tr)
CA (1) CA2401637C (tr)
DE (1) DE60103868T2 (tr)
DK (1) DK1268469T3 (tr)
EA (1) EA004986B1 (tr)
EE (1) EE05084B1 (tr)
ES (1) ES2222358T3 (tr)
FR (1) FR2806722B1 (tr)
HK (1) HK1051537A1 (tr)
HR (1) HRP20020762B1 (tr)
HU (1) HUP0300695A2 (tr)
IL (2) IL151619A0 (tr)
IS (1) IS2304B (tr)
ME (1) MEP17408A (tr)
MX (1) MXPA02009276A (tr)
NO (1) NO324835B1 (tr)
PL (1) PL204660B1 (tr)
PT (1) PT1268469E (tr)
RS (1) RS50370B (tr)
SI (1) SI1268469T1 (tr)
SK (1) SK286687B6 (tr)
TR (1) TR200402343T4 (tr)
TW (1) TWI290141B (tr)
UA (1) UA71667C2 (tr)
WO (1) WO2001070736A1 (tr)
ZA (1) ZA200206996B (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
CA2508165C (en) * 2002-12-06 2014-05-06 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
WO2005102991A1 (ja) * 2004-04-19 2005-11-03 Daiso Co., Ltd. 非天然型アミノ酸の製造方法およびその中間体
US7750162B2 (en) 2004-04-19 2010-07-06 Daiso Co., Ltd. Process for preparation of nonnatural amino acid and intermediate thereof
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
WO2009126675A1 (en) * 2008-04-09 2009-10-15 Boehringer Ingelheim International Gmbh 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
EP2294051B1 (en) * 2008-05-22 2014-08-13 Boehringer Ingelheim International GmbH Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
US8598206B2 (en) * 2010-01-28 2013-12-03 The Medicines Company (Leipzig) Gmbh Trypsin-like serine protease inhibitors, and their preparation and use
FR2981071B1 (fr) * 2011-10-10 2014-02-07 Centre Nat Rech Scient Synthese versatile et stereospecifique d'acides amines gamma,delta-insatures par la reaction de wittig

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2756285B1 (fr) * 1996-11-22 1998-12-18 Synthelabo Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
FR2756220B1 (fr) * 1996-11-27 1998-12-24 Lorraine Laminage Roue pour vehicule terrestre a moteur
FR2771094B1 (fr) * 1997-11-19 2000-02-04 Synthelabo Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
SI1268469T1 (en) 2004-10-31
HK1051537A1 (en) 2003-08-08
DK1268469T3 (da) 2004-10-11
TWI290141B (en) 2007-11-21
PL204660B1 (pl) 2010-01-29
HRP20020762A2 (en) 2003-12-31
EP1268469B1 (fr) 2004-06-16
IS6535A (is) 2002-08-30
DE60103868D1 (de) 2004-07-22
DE60103868T2 (de) 2005-06-09
RS50370B (sr) 2009-11-10
KR100791693B1 (ko) 2008-01-03
IL151619A (en) 2009-05-04
FR2806722A1 (fr) 2001-09-28
HUP0300695A2 (hu) 2003-07-28
ATE269325T1 (de) 2004-07-15
NO20024496L (no) 2002-11-22
MEP17408A (en) 2010-06-10
CN1183128C (zh) 2005-01-05
SK13512002A3 (sk) 2003-03-04
EE200200540A (et) 2004-04-15
EA004986B1 (ru) 2004-10-28
BR0109385A (pt) 2003-06-03
UA71667C2 (uk) 2004-12-15
HRP20020762B1 (en) 2005-02-28
US20030207920A1 (en) 2003-11-06
CN1426407A (zh) 2003-06-25
WO2001070736A1 (fr) 2001-09-27
CA2401637A1 (en) 2001-09-27
AR029900A1 (es) 2003-07-23
ZA200206996B (en) 2003-09-01
JP2003528098A (ja) 2003-09-24
EP1268469A1 (fr) 2003-01-02
AU4661701A (en) 2001-10-03
KR20020081476A (ko) 2002-10-26
MXPA02009276A (es) 2003-05-23
NO20024496D0 (no) 2002-09-19
EA200200838A1 (ru) 2003-04-24
AU2001246617B2 (en) 2006-03-02
PT1268469E (pt) 2004-10-29
PL364988A1 (en) 2004-12-27
NO324835B1 (no) 2007-12-17
ES2222358T3 (es) 2005-02-01
US6680329B2 (en) 2004-01-20
BG107130A (bg) 2003-06-30
EE05084B1 (et) 2008-10-15
FR2806722B1 (fr) 2002-05-17
CA2401637C (en) 2009-11-10
BG65863B1 (bg) 2010-03-31
SK286687B6 (sk) 2009-03-05
YU67002A (sh) 2005-07-19
IS2304B (is) 2007-10-15
IL151619A0 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
NO20006323L (no) Glykopeptid-derivater og farmasöytiske sammensetninger som inneholder disse
BR9916111A (pt) Derivados de fenilglicina
BR9913745A (pt) Cetonas de piridina úteis como herbicidas
DK1200418T3 (da) Nematodicide trifluorbutener
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE308529T1 (de) Arylsulfonamide als antivirale mittel
TR200402343T4 (tr) Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
TR200101979T2 (tr) Antidepresyon tedavisi için 5HT1 antagonistleri.
DE69320352T2 (de) Piperidinylamide, sulfonamide und sulfoxamide als inhibitoren der cholesterin biosynthese
SE9904128D0 (sv) Novel compounds
BR0110490B1 (pt) agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina.
ATE256466T1 (de) Verwendung von manzaminen als entzündungshemmende mittel
NO20030500D0 (no) Dihydroporfyrinderivater og deres anvendelse
DK1144423T3 (da) Bis-terpyridin-platin(II)-komplekser
DK1051404T3 (da) Substituerede phenyluraciler med herbicid virkning
DK1098878T3 (da) Bispiperidiner som antitrombotiske midler
BR0109607A (pt) Agentes de tingimento contendo derivados de 1,3-diamino-4heteroaril-benzeno para fibras de queratina bem como derivados de 1,3-diamino-4-heteroaril-benzeno
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase
PT1140932E (pt) Derivados de 1,8-benzonaftiridina